M&T Bank’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-10,634
| Closed | -$189K | – | 1559 |
|
2025
Q1 | $189K | Sell |
10,634
-1,750
| -14% | -$31.1K | ﹤0.01% | 1426 |
|
2024
Q4 | $369K | Sell |
12,384
-457
| -4% | -$13.6K | ﹤0.01% | 1295 |
|
2024
Q3 | $201K | Sell |
12,841
-3,178
| -20% | -$49.7K | ﹤0.01% | 1523 |
|
2024
Q2 | $275K | Buy |
16,019
+913
| +6% | +$15.6K | ﹤0.01% | 1351 |
|
2024
Q1 | $236K | Buy |
+15,106
| New | +$236K | ﹤0.01% | 1430 |
|
2023
Q3 | – | Sell |
-4,979
| Closed | -$206K | – | 1583 |
|
2023
Q2 | $206K | Buy |
4,979
+22
| +0.4% | +$911 | ﹤0.01% | 1462 |
|
2023
Q1 | $298K | Buy |
4,957
+1,058
| +27% | +$63.5K | ﹤0.01% | 1305 |
|
2022
Q4 | $286K | Sell |
3,899
-876
| -18% | -$64.3K | ﹤0.01% | 1323 |
|
2022
Q3 | $362K | Sell |
4,775
-301
| -6% | -$22.8K | ﹤0.01% | 1208 |
|
2022
Q2 | $347K | Sell |
5,076
-193
| -4% | -$13.2K | ﹤0.01% | 1126 |
|
2022
Q1 | $435K | Buy |
5,269
+2,292
| +77% | +$189K | ﹤0.01% | 1051 |
|
2021
Q4 | $224K | Buy |
2,977
+211
| +8% | +$15.9K | ﹤0.01% | 1391 |
|
2021
Q3 | $322K | Sell |
2,766
-379
| -12% | -$44.1K | ﹤0.01% | 1199 |
|
2021
Q2 | $697K | Buy |
3,145
+238
| +8% | +$52.7K | ﹤0.01% | 881 |
|
2021
Q1 | $383K | Sell |
2,907
-3,117
| -52% | -$411K | ﹤0.01% | 1116 |
|
2020
Q4 | $1.04M | Sell |
6,024
-126
| -2% | -$21.8K | ﹤0.01% | 760 |
|
2020
Q3 | $685K | Buy |
6,150
+2,647
| +76% | +$295K | ﹤0.01% | 842 |
|
2020
Q2 | $208K | Sell |
3,503
-5
| -0.1% | -$297 | ﹤0.01% | 1363 |
|
2020
Q1 | $236K | Buy |
3,508
+163
| +5% | +$11K | ﹤0.01% | 1258 |
|
2019
Q4 | $282K | Sell |
3,345
-229
| -6% | -$19.3K | ﹤0.01% | 1115 |
|
2019
Q3 | $267K | Sell |
3,574
-639
| -15% | -$47.7K | ﹤0.01% | 1263 |
|
2019
Q2 | $266K | Buy |
4,213
+13
| +0.3% | +$821 | ﹤0.01% | 1289 |
|
2019
Q1 | $202K | Buy |
+4,200
| New | +$202K | ﹤0.01% | 1414 |
|